One study reported a higher proportion of psychiatric and parkinsonian symptoms in TREM2 p.R47H carriers who received an Alzheimer’s disease diagnosis [20], while others failed to find any distinguishing clinical symptoms [21, 22]. Here, TREM2 is linked to Alzheimer disease.